• About us
    • Successful cases
    • R+D
    • Clients
    • News
  • Particle
    technologies
  • Particle characterization
    • Services
      • Development and validation of PSD methods
      • Determination of accuracy of PSD methods
      • Particle morphological characterization
      • Solid state and crystallographic studies
      • Nano-Characterization
      • Analytical Development
    • Analysis
      • Granulometry - PSD
        • Laser Diffraction
        • Automated Optical Microscopy
      • Particle Morphology
        • Automated Optical Microscopy
        • Electron Microscopy
      • Nanoparticle Analysis
        • Dynamic Light Scattering
        • CRYO-TEM
      • Chemical Composition
        • HPLC (High-Performance Liquid Chromatography)
        • Image Analysis from Optical and Electron Microscopy
    • Quality
    • Case Studies
      • Analytical support into raw materials supplier qualification
      • Analytical investigation on OOS samples
      • Analytical investigation to support IP and regulatory procedures
      • Characterisation of nanostructures and nanoformulations
      • Comparison between development/test samples and Reference Drug Product/RLD samples
      • Image analysis studies from optical and electron microscopy
  • Contact us

News

2022
Liposomal formulations for treating lysosomal storage disorders

Liposomal formulations for treating lysosomal storage disorders

22 November 2022
PHOENIX-OITB Launches Open Call Offering Funded Services in Nanopharmaceutical Development

PHOENIX-OITB Launches Open Call Offering Funded Services in Nanopharmaceutical Development

17 October 2022
NANOMOL TECHNOLOIES in the LABFORUM Workshops

NANOMOL TECHNOLOIES in the LABFORUM Workshops

27 July 2022
Measurement of Particle Size Distribution of ceramic powders by laser diffraction

Measurement of Particle Size Distribution of ceramic powders by laser diffraction

25 July 2022
Translation of DELOS nanovesicles formulations into new pharmaceutical candidates by Lídia Ballell

Translation of DELOS nanovesicles formulations into new pharmaceutical candidates by Lídia Ballell

22 July 2022
BBQ2022 with CataloniaBio & HealthTech

BBQ2022 with CataloniaBio & HealthTech

18 July 2022
Training sessions for Farmhispania Group

Training sessions for Farmhispania Group

11 July 2022
Applications of ALBA Synchrotron for the pharmaceutical industry

Applications of ALBA Synchrotron for the pharmaceutical industry

20 June 2022
Networking and Beers

Networking and Beers

23 May 2022
Nanomol, one of the 10 companies selected for the BIOMED ScaleUP program

Nanomol, one of the 10 companies selected for the BIOMED ScaleUP program

16 May 2022
Nanomol Technologies, one of the 30 finalists in the 2nd edition of Catalonia Exponential Leaders

Nanomol Technologies, one of the 30 finalists in the 2nd edition of Catalonia Exponential Leaders

02 May 2022
World Intellectual Property Day

World Intellectual Property Day

26 April 2022
  • First
  • 01
  • 02
  • 03
  • Last

come and visit us

NANOMOL TECHNOLOGIES, S.L.
Mòdul de Recerca B
UAB CAMPUS

08193 Bellaterra
Cerdanyola del Vallès
Barcelona
Spain

get in touch

T +34 935 868 963
INFO@NANOMOL-TECH.COM

follow us

Twitter Linkedin

terms of use

Privacy policy Legality Cookies

Copyright © 2026

Nanomol Technologies S.L.

Site by Suki